Louis Kayitalire - 04 Oct 2021 Form 4 Insider Report for F-star Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
04 Oct 2021
Net transactions value
-$462
Form type
4
Filing time
06 Oct 2021, 16:38:55 UTC
Previous filing
07 Jul 2021
Next filing
04 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Sale $462 -64 -0.12% $7.23 54,319 04 Oct 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
F2 Includes 47,175 restricted stock units.